LFST
LifeStance Health Group, Inc.
Last earnings +20.2% on 2026-05-07
$10.28
▲ +4.05%$10.28▲ +112.84%
over 1Y
L $3.79EODHDH $10.28
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+4.0%
1W+11.7%
1M+35.1%
3M+62.7%
YTD+47.7%
1Y+112.8%
Hold
Conviction
Horizon
Medium (3–12mo)
12-mo target
$•••
Street · 17 analysts
Buy
LFST crossed into GAAP profitability with strong cash generation, but razor-thin margins and payor concentration keep it a 'show-me' hold.
LifeStance just printed its first profitable year as a public company — FY2025 revenue of $1.42B grew 13.9% YoY while net income flipped from -$57.4M to +$9.66M, and operating income jumped 176.4% to $24.1M. The trajectory is unmistakable: losses have narrowed every year since FY2021 (-$307M → -$216M → -$186M → -$57M → +$10M), and FY2025 operating cash flow of $146M (up 36.3%) with cash on hand climbing to $249M (+60.9%) confirms the business is now self-funding. The 10-K's MD&A reinforces this — management explicitly states existing cash is sufficient for the next 12 months 'without any additional financing,' and the 2024 Credit Agreement carries a much friendlier SOFR+3.00% rate (vs. the old SOFR+4.50%) with a Total Net Leverage covenant ceiling of 4.50x that the company is comfortably under given $146M of OCF against $283M of principal.
Financials · annual, by fiscal year
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $668M | $860M | $1.06B | $1.25B | $1.42B |
| Gross profit | — | — | — | — | — |
| Operating income | -$286M | -$210M | -$189M | -$31.6M | $24.1M |
| Net income | -$307M | -$216M | -$186M | -$57.4M | $9.66M |
| Diluted EPS | — | — | — | — | — |
| Net margin | -46.0% | -25.1% | -17.6% | -4.6% | 0.7% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Key statistics
Valuation
Enterprise value$4.04B
EV / EBITDA61.4
EV / Sales2.8
EV / FCF36.7
P / FCF36.4
PEG (trailing)—
Earnings yield0.2%
FCF yield2.7%
Quality & risk
ROIC (est.)1.1%
Free cash flow$110M
Total debt$280M
Net cash-$31.8M
Altman Z-Score3.78 safe
Piotroski F-Score7/8
Capital returns
Buyback yield—
Dividend yield (est.)—
Shareholder yield—
Shares Δ YoY+1.4%
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Disclosure timeline
SEC · 8-Ks + reportsRecent disclosure tone has been improving.
- 8-K Shareholder vote2026-06-04
Annual meeting vote results disclosed; routine director and auditor approvals
- 8-K Other event2026-05-12
Other corporate event disclosed with exhibits; no material financial impact flagged
- 8-K Earnings results2026-05-07
Q1 2026 10-Q filed; building on first profitable year with $249M cash on hand
- 10-Q Quarterly report2026-05-07
Q1 2026 10-Q filed; building on first profitable year with $249M cash on hand
- DEF 14A Proxy statement2026-04-22
2026 proxy statement; routine governance and executive comp disclosures
- 8-K Officer / director change2026-03-11
Executive or director transition announced (Item 5.02)
- 8-K Other event2026-03-02
Other corporate event disclosed with exhibits post FY2025 results
- 8-K Officer / director change2026-02-25
First full-year GAAP profit ($9.7M); revenue +13.9%, OCF +36% to $146M
- 10-K Annual report2026-02-25
First full-year GAAP profit ($9.7M); revenue +13.9%, OCF +36% to $146M
Recent filings
all on EDGAR ↗144Filing2026-06-26open ↗4Period ending 2026-06-112026-06-15open ↗8-KPeriod ending 2026-06-022026-06-04open ↗SCHEDULE 13G/AFiling2026-05-15open ↗4Period ending 2026-05-122026-05-14open ↗4Period ending 2026-05-122026-05-14open ↗4Period ending 2026-05-122026-05-14open ↗4Period ending 2026-05-122026-05-14open ↗8-KPeriod ending 2026-05-072026-05-12open ↗4Period ending 2026-05-072026-05-11open ↗SCHEDULE 13G/AFiling2026-05-08open ↗424B7Filing2026-05-08open ↗
Frequently asked
- Is LifeStance Health Group, Inc. (LFST) a buy?
- LFST currently carries a Hold rating with 3/5 conviction, derived from its latest SEC filings. LFST crossed into GAAP profitability with strong cash generation, but razor-thin margins and payor concentration keep it a 'show-me' hold.
- What is LifeStance Health Group, Inc.'s quality score?
- LFST scores 70.33333333333333/100 (grade B) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.
Sources: SEC EDGAR (CIK 0001845257, latest 10-Q filed 2026-05-07) · EODHD · analysis by claude-code · as of 6/25/2026, 1:24:18 PM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.